A Clinical Trial of TQB3006 Tablets in Patients With Advanced Malignant Cancer

Clinical trial NCT06344351 · COMPLETED

Trial details

NCT number: NCT06344351
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Malignant Neoplasm

Start date: 2024-04-25
Primary completion: 2025-05-20
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.